vTv Therapeutics Inc Capital Reinvestment Ratio

Latest as of June 2022: 0.03x

vTv Therapeutics Inc capital reinvestment ratio. vTv Therapeutics Inc (VTVT) has a Capital Reinvestment Ratio of 0.03x as of June 2022, meaning it reinvests 0% of its operating cash flow ($706.00K) in capital expenditures ($21.00K). Check how aggressively does vTv Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$706.00K

USD

Capital Expenditures

$21.00K

USD

Data as of

Jun 2022

Most recent filing

vTv Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

vTv Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash efficiency ratio of vTv Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow